All In Biotech

Free tool

FAERS Monitor: Torisel

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022088 or its brand name (Torisel, Temsirolimus). Reports on generic versions are filed under their own applications.

Reports

4,506

Serious

3,854

86% of reports

Hospitalization

2,003

Death reported

969

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • disease progression479
  • death287
  • dyspnoea216
  • fatigue206
  • pneumonia190
  • diarrhoea189
  • nausea189
  • anaemia188
  • pyrexia179
  • vomiting176
  • thrombocytopenia164
  • dehydration162
  • stomatitis156
  • rash143
  • renal cell carcinoma136

Reports by year received

View as table
YearReports
20064
2007132
2008422
2009352
2010523
2011426
2012538
2013399
2014279
2015328
2016247
2017153
2018132
2019119
2020106
202179
2022138
202360
202444
202516
20269

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,653 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
renal cell carcinomaSignal136133.4112.817,256
disease progressionSignal47919.017.48,148
stomatitisSignal15612.010.31,568
thrombocytopeniaSignal1646.95.9817
dehydrationSignal1625.74.9622
anaemiaSignal1884.64.0531
pneumoniaSignal1902.72.4211
pyrexiaSignal1792.42.1149
dyspnoea2161.81.675
vomiting1761.71.557
death2871.61.459
rash1431.51.326
diarrhoea1891.41.219
fatigue2061.21.19
nausea1891.11.02

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.